People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Urotronic, Inc. | — | Other Health Care | Series B | $38.5M | $253.9M | 2018 |
| Optilume Stricture, LLC | — | Other Health Care | Pre-Seed | $954K | $25.8M | 2020 |
Tan Ching at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tan Ching on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Perry | 2 | 11 |
| Lixiao Wang | 2 | 4 |
| Hui Hu | 2 | 4 |
| Jeff Thomas | 2 | 4 |
| Doug Kohrs | 2 | 3 |
| Yuriy Prilutskiy | 2 | 3 |
| Rushu Luo | 1 | 3 |
| Junfeng Wang | 1 | 1 |
| Jafar Wang | 1 | 1 |
| Robert Luo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.